Nutraceutical Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Path to Liver Health
Nutrients · 13.05.2025 · 17 (10) · 1657
DOI: 10.3390/nu17101657 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 13.05.2025. Verfasst von Emmanouil Vrentzos und 6 weiteren Autor:innen. Beteiligte Einrichtung: 4th Department of Internal Medicine, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greec…. Hauptthemen laut MEDLINE: Dietary Supplements, Fatty Liver, Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) is a growing global concern. Nutraceuticals offer an appealing approach by targeting key mechanisms, such as oxidative stress, inflammation, lipid metabolism, and insulin resistance. This narrative review examines the role of various nutraceuticals in MASLD treatment, including silymarin, vitamin E, omega-3, curcumin, berberine, and coenzyme Q10. Some of them show promising biochemical and metabolic changes, while others produce conflicting results due to relevant studies’ design and endpoints. To bridge the gap between research and reality, we summarize the data, create an interpretation heatmap, and develop a practical supplement guide. Regardless of their potential, nutraceuticals should be viewed as add-ons to lifestyle interventions rather than standalone treatments. Future research should focus on well-designed, long-term studies to prove efficacy, dosing, and combination strategies for personalized MASLD management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 4th Department of Internal Medicine, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.
- 2nd Department of Internal Medicine, Research Unit and Diabetes Center, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.
ORCID-Profile: Emmanouil Vrentzos, George Pavlidis, Emmanouil Korakas, Aikaterini Kountouri, Loukia Pliouta, George D Dimitriadis
Zitieren
APA
Vrentzos, E., Pavlidis, G., Korakas, E., Kountouri, A., Pliouta, L., Dimitriadis, G. D., & Lambadiari, V. (2025). Nutraceutical Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Path to Liver Health. Nutrients, 17(10), 1657. https://doi.org/10.3390/nu17101657
Vancouver
Vrentzos E, Pavlidis G, Korakas E, Kountouri A, Pliouta L, Dimitriadis GD, et al. Nutraceutical Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Path to Liver Health. Nutrients. 2025;17(10):1657. doi:10.3390/nu17101657
BibTeX
@article{Vrentzos2025,
author = {Vrentzos, Emmanouil and Pavlidis, George and Korakas, Emmanouil and Kountouri, Aikaterini and Pliouta, Loukia and Dimitriadis, George D and Lambadiari, Vaia},
title = {Nutraceutical Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Path to Liver Health},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {10},
pages = {1657},
doi = {10.3390/nu17101657}
}
EUVIMED